1. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Office of Generic Drugs. Approved drug products with therapeutic equivalence evaluations (Orange Book) [database on the Internet]. 27th ed. 2006 January [updated 2008 Jan; cited 2008 Apr 7]. Available from: URL http://www.fda.gov/cder/ob/.
2. Maximizing generic utilization: the power of pharmacy benefit management;Snow;J Gen Med,2007
3. The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine;Duh;Dis Manage,2007
4. Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting;LeLorier;Curr Med Res Opin,2008
5. Current approaches to the use of antiepileptic drugs;Kramer;Epilepsy Behav,2007